SLC7A11 and esophageal squamous cell carcinoma: We analyzed the correlation between the clinicopathological characteristics, including the expression of SLC7A11 and NRF2 and the efficacy of CRT, and the results demonstrated that higher expression levels of SLC7A11 and NRF2 were related to a poor therapy response in patients with ESCC who received CRT.